Investing in the Future of Precision Cancer Medicine

Developing a first-in-class, 3rd generation Polo-like Kinase 1 (PLK1) Inhibitor to treat leukemias, lymphomas
and solid tumor cancers

19th Annual Rodman & Renshaw Global Investment Conference
September 12, 2017
5:05pm - 5:30pm EDT
Venue
Lotte New York Palace
Hotel

Trovagene CEO, Bill Welch, will present an overview of the Company at the 19th Annual Rodman & Renshaw Gloabl Investment Conference on Tuesday, September 12th, at 5:05 pm EDT at the Lotte New York Palace in New York City, NY. The presentation will be webcast live. To access the webcast, please visit http://wsw.com/webcast/rrshq27/trov.  The webcast replay will remain available for 90 days following the live presentation.